In this issue of Clinics in Chest Medicine, guest editors Drs. Scott Evans, Guang-Shing Cheng, Julio Ramirez, and Bashar Staitieh bring their considerable expertise to the topic of Pulmonary Disease in the Immunocompromised Host. Top experts discuss imaging the immunocompromised lung; laboratory molecular testing in immunocompromised host pneumonia; vaccines and other preventative strategies for immunocompromised pneumonia; adjunctive/host-directed therapies in immunocompromised host pneumonia; sequelae of immunocompromised host pneumonia; and more.
Algorithmic Approach to an Abnormal Computed Tomography of the Chest in the Immunocompromised Host Vaccines and Other Preventative Strategies for Immunocompromised Pneumonia Host-Directed Adjunctive Therapies in Immunocompromised Patients with Pneumonia Sequelae of Immunocompromised Host Pneumonia Evaluation of Inborn Errors of Immunity Among Patients with Opportunistic Pulmonary Infection The Microbiome and Pulmonary Immune Function Smoking, Alcohol Use, Diabetes Mellitus, and Metabolic Syndrome as Risk Factors for Community-Acquired Pneumonia Acute Lung Injury in Immunocompromised Patients Pulmonary Complications in Hematologic Malignancies Pulmonary Immunocompromise in Stem Cell Transplantation and Cellular Therapy Pulmonary Immunocompromise in Solid Organ Transplantation Pulmonary Immunocompromise in Chronic and High-dose Steroid Therapy Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases Pulmonary Immunocompromise in Human Immunodeficiency Virus Disease Coronavirus Disease 2019 and Emerging Lung Infections in the Immunocompromised Patient
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.